TO:
|
The Securities Commissions in each of the Provinces of Canada
|
1.
|
this certificate is delivered pursuant to section 2.20 of National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer (“NI 54-101”) and in connection with the mailing of the Corporation’s proxy-related materials for its Annual Meeting to be held on November 30, 2010 (the “Meeting”);
|
2.
|
the Corporation has arranged to have proxy-related materials for the Meeting sent in compliance with NI 54-101 to all beneficial owners at least 21 days before the date fixed for the Meeting;
|
3.
|
the Corporation has arranged to have carried out all of the requirements of NI 54-101 in addition to those prescribed in paragraph 2 above; and
|
4.
|
with respect to the Meeting, the Corporation is relying upon section 2.20 of NI 54-101 to abridge the time prescribed in subsection s. 2.2(1) NI 54-101.
|
LORUS THERAPEUTICS INC.
|
||
By:
|
“Elizabeth Williams”
|
|
Elizabeth Williams
Director of Finance and Acting Chief Financial Officer
|